Carr Douglas 4

What Happened
Carr Douglas, Senior Vice President of Finance & Operations at Century Therapeutics (IPSC), sold 7,043 shares on 2026-03-12 at $2.55 per share for a total of $17,953. The transaction is reported as a sale and was done to satisfy tax withholding obligations tied to vested restricted stock units (RSUs), per the filing footnote.

Key Details

• Transaction date: 2026-03-12; Price: $2.55 per share; Total proceeds: $17,953.
• Transaction type: Sale (reported as open market or private sale).
• Shares owned after the transaction: not disclosed in the provided filing.
• Footnote: The sale was automatic to cover tax withholding on RSU vesting and was not at the reporting person’s discretion.
• Filing: Form 4 filed 2026-03-16 for the 2026-03-12 transaction — appears timely (within the SEC’s two business-day window).

Context
This was a routine, tax-withholding sale related to RSU vesting (common for executives when shares vest). Such automatic withholding sales are typically administrative and don’t necessarily signal a change in the insider’s view of the company. The dollar value here is modest relative to typical insider trading headlines.